In line with the previous results, co-administration of pravastatin improved vascular integration and functional recovery, confirming the therapeutic potential of statin-mediated eNOS/NO pathway activation in reversing obesity-induced endothelial dysfunction. Here, NOS3 is linked to obesity disorder.